Volta Medical
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
219 10,960Global tags
Activities
Technologies
Entity types
Location
65 Av. Jules Cantini, 13006 Marseille, France
Marseille
France
Employees
Scale: 51-200
Estimated: 132
SIREN
474510013Engaged corporates
14
10 3Added in Motherbase
3 years, 7 months ago
healthtech Value proposition
Our Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysiology.
Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures.
Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, VX1, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With VX1, operators keep their go-to navigation system and catheters.
The VX1 real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation.
VX1 is CE marked and FDA cleared. VX1 was the first artificial intelligence-based software solution to be FDA cleared in the interventional cardiology space.
Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.
Medical Device, Machine Learning, Deep Learning, Cardiac Electrophysiology, MedTech, atrial Fibrillation, and SoftwareOriginal language
Our Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysiology.
Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures.
Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, VX1, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With VX1, operators keep their go-to navigation system and catheters.
The VX1 real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation.
VX1 is CE marked and FDA cleared. VX1 was the first artificial intelligence-based software solution to be FDA cleared in the interventional cardiology space.
Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.
Volta Medical
https://www.volta-medical.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 15 Sep 2021 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 28 Apr 2021 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 22 May 2024 | | |
 EU-Startups Media, Software Development | EU-Startups Media, Software Development | Capitalistic Not partnership Not event 8 Jan 2021 | | |